In June 2022, Edenbridge Pharmaceuticals, LLC became a wholly-owned subsidiary of Dexcel Pharma. Dexcel Pharma is the largest private pharmaceutical company in Israel, commercializing an extensive portfolio of branded and generic drugs in Israel and various countries...
IN THE NEWS
Updates that matter. News to know.
Stay informed with the latest company news, product updates, and media coverage from Dexcel Pharma USA. From scientific advancements to industry insights, this is where we share the moments that shape our mission and move healthcare forward.
In The News
Pantoprazole Sodium for Delayed-Release Oral Suspension Launch
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Pantoprazole Sodium for Delayed-Release Oral Suspension, a generic version of Protonix®* for delayed-release oral suspension. Pantoprazole Sodium for Delayed-Release Oral...
Isosorbide Mononitrate Extended-Release Tablets, USP Launch
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Isosorbide Mononitrate Extended-Release Tablets, USP, a generic version of Imdur Extended-Release Tablets. Isosorbide Mononitrate Extended-Release Tablets, USP, are indicated...
Diclofenac Sodium Extended-Release Tablets, USP and Venlafaxine Extended-Release Tablets, USP Launch
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of two new molecules into the U.S. market: Diclofenac Sodium Extended-Release Tablets, USP, a generic version of Voltaren®*-XR Tablets and Venlafaxine Extended-Release Tablets....
Vigabatrin Tablets, USP Launch
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Vigabatrin Tablets USP, 500mg, a generic version of Sabril®* Tablets, 500mg. Vigabatrin Tablets USP, 500mg are indicated as adjunctive therapy for refractory complex partial...
Prednisolone Sodium Phosphate Oral Solution (15mg per 5mL & 25mg per 5mL) Approval
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Prednisolone Sodium Phosphate Oral Solution to include the 15 mg Prednisolone...
Amantadine Hydrochloride Tablets Approval
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Amantadine Hydrochloride Tablets, 100mg, a generic version of Symmetrel®*...
Doxepin Hydrochloride Capsules, USP Approval
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Doxepin Hydrochloride Capsules USP, 150mg, a generic version of Sinequan...
DARTISLA ODT (glycopyrrolate) Orally Disintegrating Tablets Launch
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies...
DARTISLA ODT (Glycopyrrolate) Orally Disintegrating Tablets Approval
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received approval from the U.S. Food and Drug Administration on its 505(b)(2) New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets. DARTISLA ODT...
Explore Dexcel Pharma USA

Meet Our Leadership
Our leadership team brings together deep industry expertise, strategic vision, and a shared passion for improving patient lives.

Explore Our Resources
Explore the latest developments at Dexcel Pharma USA, detailed product information, and opportunities for business development partnerships.

Partner With Us
We are committed to building long-term partnerships in every aspect of our business.